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High time for a paradigm shift in psychiatry  
 
There is no doubt that several people, especially during their childhood and adolescence, have 
some sort of psychotic-like experiences, and that only a minority of them go on to develop a serious 
psychiatric disease. We completely agree on this with van Os and Reininghaus1, although the 
prevalence of psychotic-like experiences in the population is still not clear, because it strongly 
depends on methodological issues, such as the definition of these experiences, the type of 
prevalence (e.g., annual or lifetime) reported, the representativeness of the study sample and the 
age group investigated, the method of assessment (usually self-rating questionnaires or standardized 
interviews administered by laypersons, which do not allow for checking alternative explanations for 
the psychotic experiences or for assessing the grade of certainty), and the consideration of 
influencing factors such as cannabis abuse2,3.  
The "continuity" of psychosis is not an exception in medicine. We know quite well that many 
people are sometimes depressed or anxious without ever developing a depressive or anxiety 
disorder, and that many people sometimes have a cough without developing a serious lung disease. 
Regarding the continuity of psychosis, G. Huber4 already in the 1980s described the 
"Vorpostensymptome" (“outpost symptoms”), basic and prodromal symptoms preceding the 
outbreak of frank psychosis, and we later replicated these findings in a large representative sample 
with Häfner and others5. 
Based on these findings and P. McGorry's initiative of assessing this insidious onset of psychosis 
prospectively, early detection of psychosis was established6. Thus, acknowledging the continuity of 
psychosis has opened the door for its early detection. Many centers in the world have in the 
meantime shown that transition to frank psychosis can be predicted with a relatively high accuracy 
by carefully assessing these early signs and symptoms in help-seeking individuals: about 37% of those 
fulfilling the risk criteria develop psychosis within three years, mainly schizophrenia spectrum 
disorders6,7, although psychotic transition was most likely prevented in some patients by caring for 
them in the early intervention services.  
The big question, however, always was: when do psychotic-like experiences really predict later 
transition to psychosis, when are they symptoms of another mental disorder, and when are they just 
harmless, transient phenomena?  
Early detection research has established quite an elaborate set of criteria for this prediction and 
is continuously trying to refine them6-8: the individuals or one of their significant others need to be 
distressed and help-seeking; they have to belong to an age group at risk; they concurrently have to 
display psychotic-like experiences such as attenuated hallucinations, unusual thought content or 
suspiciousness above a certain threshold of severity; or they must have had full-blown psychotic 
symptoms for less than one week; or they have to show a genetic risk in combination with a recent 
marked social decline, or, in some studies, with newly developed unspecific prodromal signs9; and, 
most importantly, risk assessment is based on thorough examinations by specifically trained, 
specialized psychiatrists and psychologists. More and more, additional predictors are included, such 
as (subclinical) negative symptoms or neurocognitive decline. 
Well aware of the fact that psychotic experiences can be "transdiagnostic" phenomena, patients 
in early detection services are usually diagnosed according to the diagnostic criteria they fulfil (mainly 
depressive or anxiety disorders) and, in addition to that, they are educated about their potential risk 
of going on to develop some sort of psychotic disorder. So, there is not a "mislabelling as ultra-high 
risk status", as stated by van Os and Reininghaus1, but the transdiagnostic nature of psychotic-like 
experiences is taken into account, which is exactly what van Os and Reininghaus demand. 
Fortunately, about two thirds of these individuals do not develop frank psychosis and some of them 
completely recover. In these cases, early treatment may have been beneficial not only for their 
psychotic-like symptoms, but also for the other symptom dimensions.  
Acknowledging continuity also offers a chance for destigmatization. Educating patients, their 
significant others and the general population about the continuity of mental health problems often 
brings great relief and opens the door for the "coming out" of those concerned and a better 
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understanding by those not (or not yet) concerned. At the same time, it is a step away from an old 
patriarchal psychiatry in which patients were not educated about their diagnoses and risks. 
However, if we acknowledge that mental (not only psychotic) symptoms are often continuous  
temporally as well as phenomenologically  and cross the borders of traditional categories, does that 
really mean that we need new diagnostic approaches? 
Clearly defined, reliable diagnostic categories brought great progress into psychiatry  research 
and clinic  some decades ago. But are these categories really valid entities? We suppose we have to 
admit that they are not. What was a progress some decades ago is not satisfying anymore, because 
research in psychiatry has made significant progress in the meantime, enabling us to enter a process 
which other medical specialties such as internal medicine have entered much earlier. Our colleagues 
there are well beyond deriving diagnoses from the presenting symptoms only, such as different sorts 
of coughing, aspects of sputum etc., but have learned to also use the "biomarkers" of their patients 
by means of X-rays, bacteriological analyses etc. and thereby learned that one and the same 
symptom can have completely different aetiologies, which is the basis for their diagnoses (e.g., 
pneumonia, tuberculosis or lung cancer). 
Psychiatry in the meantime also has developed this potential of identifying disorders based on 
aetiology or at least suspected pathogenetic mechanisms rather than only on presenting symptoms. 
The challenge is now to use emerging research findings for identifying new, valid, aetiologically 
defined disease entities. To this end, data from genetics, neuroimaging, neurocognition, 
neurophysiology, neuroendocrinology, immunology etc. should be used, but also data on 
psychosocial pathogenetic influences such as environmental stressors and triggers8.  
In order to derive such new, aetiologically valid entities, research has to be free from 
preconceived assumptions and specifications and should be purely data-driven in a first step. All the 
above-mentioned assessment modalities have to be integrated. Dimensional rather than categorical 
approaches should be used in a first step, in order to avoid loss of data. Furthermore, data have to be 
derived from large populations with mental problems and not from specific, pre-defined traditional 
and to some extent artificial categories of patients. Thinking in silos has rarely brought progress. 
New statistical methods, e.g. latent variable mixture models10 or unsupervised machine 
learning11, could allow for such new transdiagnostic, assumption-free, multi-domain approaches, 
which are not just based on psychopathology but mainly on aetiopathogenetic factors  
neurobiological as well as psychosocial ones. 
Thus, expanding on van Os and Reininghaus' suggestions, we propose an even more radical 
paradigm shift in psychiatry. Hopefully, our discipline and our patients can, in the future, benefit 
from such new approaches in many ways: a) in the general population, a more dimensional concept 
of mental symptoms would foster destigmatization and early detection; b) in research, more valid, 
aetiologically defined disease entities could be identified; c) in the clinic, these new entities would 
hopefully allow for more causal therapies.  
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